USSTOCK.TODAY
Regular Market
Log in Sign up

BridgeBio Pharma faces tug-of-war between falling stock price and revenue growth ahead of Q3 results

Earnings Whispers ·

BBIO
BBIO BridgeBio Pharma Inc
$68.12 +0.56%
View chart & analysis →
  1. 1BridgeBio's projected Q3 revenue of $293.7 million represents a 143.4% increase year-over-year.
  2. 2BridgeBio's cash of approximately $1.7 billion was secured through $1 billion in funding.
  3. 3BridgeBio's stock price has fallen 22.2% since the last report.

So what's the key point?

BridgeBio's Q3 revenue is expected to increase by 143.4% compared to last year. However, the stock price has already dropped 22.2%, creating a conflict between revenue growth and the declining share price.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Nine Mid-Size Drugmakers Agree to Cut Prices, Invest $19.6B in U.S. Factories Stocktwits +1 · Sep 1BridgeBio (BBIO) reports Q2 loss of $152.2 million, $0.78 per share Associated Press +1 · Aug 11Curbline Properties Beats Q3 Revenue and Raises 2026 OFFO Guidance Earnings Whispers · 1h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news